Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

The Hidden Nasty In AstraZeneca plc’s Latest Results

| Roland Head

AstraZeneca plc (LON:AZN) is a fine company, but Roland Head has noticed a disturbing trend in the firm's clinical trials…

Read more »

Investing Articles

Why AstraZeneca plc Should Be A Winner Next Year

| Alan Oscroft

AstraZeneca plc (LON:AZN) is heading back to strength in 2014.

Read more »

Investing Articles

How Will AstraZeneca Plc Fare In 2014?

| Kevin Godbold

Should I invest in AstraZeneca plc (LON: AZN) for 2014 and beyond?

Read more »

Investing Articles

3 FTSE Shares Hitting New Highs: ARM Holdings plc, AstraZeneca plc and WPP PLC

| Alan Oscroft

ARM Holdings plc (LON: ARM), AstraZeneca plc (LON: AZN) and WPP PLC (LON: WPP) climb ever higher.

Read more »

Investing Articles

Is AstraZeneca plc Set For Electrifying Earnings Growth In 2014?

| Royston Wild

Royston Wild looks at AstraZeneca plc's (LON: AZN) growth prospects for the new year.

Read more »

Investing Videos

AstraZeneca plc Doubles Down On Diabetes With $4.1bn Buyout

| Owain Bennallack

VIDEO: One Fool puts AstraZeneca plc (LON:AZN) under the spotlight.

Read more »

Company Comment

AstraZeneca PLC Doubles Down On Diabetes With $4.1bn Buyout

| Owain Bennallack

Shares in AstraZeneca PLC (LON:AZN) hit an 11-year high as investors applaud the deal.

Read more »

Investing Articles

Why WPP PLC, AstraZeneca plc and Meggitt plc Should Beat The FTSE 100 Today

| Alan Oscroft

WPP PLC (LON: WPP), AstraZeneca plc (LON: AZN) and Meggitt plc (LON: MGGT) bring us good news.

Read more »

Investing Articles

3 FTSE Shares Hitting New Highs: Ashtead Group plc, AstraZeneca plc And easyJet plc

| Alan Oscroft

Ashtead Group plc (LON: AHT), AstraZeneca plc (LON: AZN) and easyJet plc (LON: EZJ) head up and up.

Read more »

Investing Articles

Why AstraZeneca plc, Balfour Beatty plc and Huntsworth plc Should Beat The FTSE 100 Today

| Alan Oscroft

AstraZeneca plc (LON: AZN), Balfour Beatty plc (LON: BBY) and Huntsworth plc (LON: HNT) are moving up.

Read more »

Investing Articles

AstraZeneca plc’s Dividend Prospects For 2014 And Beyond

| G A Chester

G A Chester analyses the income outlook for AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

Is AstraZeneca plc Still A Buy After The 2013 FTSE Bull Run?

| Roland Head

AstraZeneca plc (LON:AZN) has kept pace with the FTSE this year, but remains an appealing recovery story.

Read more »